This article is archived and only made available for historical reference. If you’d like to discover UCSF’s most recent advances in research, education and patient care, please visit the UCSF News Center.
Archive: $6.25 Million Grant for the Memory and Aging Center
Adam Boxer, MD, PhD
FTLD strikes people at younger ages than Alzheimer’s and is uniformly fatal, but is a better defined population to develop drugs that may ultimately be effective in both FTLD and Alzheimer’s.
The network will have 14 centers around North America, including the MAC. A number of companies are interested in using these sites to test new drugs they've developed based on the science that has come out of studying FTLD.